Publication
Oligorecurrent nodal prostate cancer: Radiotherapy quality assurance of the randomized PEACE V-STORM phase II trial.
Journal Paper/Review - Apr 26, 2022
Achard Vérane, Putora Paul Martin, Zwahlen Daniel, Couñago Felipe, Scorsetti Marta, Eito Clara, Barrado Marta, Zapatero Almudena, Muto Paolo, Van De Voorde Lien, Lamanna Giorgio, Koutsouvelis Nikolaos, Dipasquale Giovanna, Ost Piet, Meersschout Sabine, Guckenberger Matthias, Jaccard Maud, Vanhoutte Frederik, Siva Shankar, Heikkilä Reino, Dirix Piet, Liefhooghe Nick, Otte François-Xavier, Gomez-Iturriaga Alfonso, Berghen Charlien, Shelan Mohamed, Conde-Moreno Antonio, López Campos Fernando, Papachristofilou Alexandros, Zilli Thomas
Units
PubMed
Doi
Contact
Citation
Type
Journal
Publication Date
Issn Electronic
Pages
Brief description/objective
Aim of this study is to report the results of the radiotherapy quality assurance program of the PEACE V-STORM randomized phase II trial for pelvic nodal oligorecurrent prostate cancer (PCa).